标题
Metabolic reprogramming in the pathogenesis of glioma: Update
作者
关键词
-
出版物
NEUROPATHOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-01-05
DOI
10.1111/neup.12535
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
- (2018) David Capper et al. ACTA NEUROPATHOLOGICA
- Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
- (2018) Ana C. deCarvalho et al. NATURE GENETICS
- Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody
- (2018) Kenta Masui et al. Biomed Research International
- Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry
- (2018) Rémi Longuespée et al. Acta Neuropathologica Communications
- The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
- (2018) Johanna Klughammer et al. NATURE MEDICINE
- mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression
- (2018) Mio Harachi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
- (2017) Ciro Zanca et al. GENES & DEVELOPMENT
- Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma
- (2017) Fahim Ahmad et al. JOURNAL OF NEUROCHEMISTRY
- mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT
- (2017) Yuchao Gu et al. MOLECULAR CELL
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
- (2017) Kristen M. Turner et al. NATURE
- Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
- (2017) Sevin Turcan et al. NATURE GENETICS
- 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
- (2017) Parker L. Sulkowski et al. Science Translational Medicine
- Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma
- (2017) Feng Liu et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- IDH mutations in cancer and progress toward development of targeted therapeutics
- (2016) L. Dang et al. ANNALS OF ONCOLOGY
- mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling
- (2016) Kenta Masui et al. BIOESSAYS
- Cancer metabolism as a central driving force of glioma pathogenesis
- (2016) Kenta Masui et al. Brain Tumor Pathology
- An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
- (2016) Genaro R. Villa et al. CANCER CELL
- Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
- (2016) Shigeo Ohba et al. CANCER RESEARCH
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Metabolic Heterogeneity in Human Lung Tumors
- (2016) Christopher T. Hensley et al. CELL
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma
- (2016) F Ahmad et al. Cell Death & Disease
- Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Glioblastoma: pathology, molecular mechanisms and markers
- (2015) Kenneth Aldape et al. ACTA NEUROPATHOLOGICA
- Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers
- (2015) Koichi Ichimura et al. ACTA NEUROPATHOLOGICA
- 2-Hydoxyglutarate:D/Riving Pathology in gLiomaS
- (2015) Daniel R. Wahl et al. BRAIN PATHOLOGY
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy
- (2015) M. C. Caino et al. CLINICAL CANCER RESEARCH
- EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling
- (2015) Feng Liu et al. MOLECULAR CELL
- Insulator dysfunction and oncogene activation in IDH mutant gliomas
- (2015) William A. Flavahan et al. NATURE
- Integrated genomic characterization of IDH1-mutant glioma malignant progression
- (2015) Hanwen Bai et al. NATURE GENETICS
- Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
- (2015) Sameer Agnihotri et al. NEURO-ONCOLOGY
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
- (2015) David Kozono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
- (2015) Kenta Masui et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas
- (2014) Denise Bechet et al. ACTA NEUROPATHOLOGICA
- mTORC2 dictates Warburg effect and drug resistance
- (2014) Kenta Masui et al. CELL CYCLE
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- mTORC2 in the center of cancer metabolic reprogramming
- (2014) Kenta Masui et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments
- (2013) K. Masui et al. CARCINOGENESIS
- Influence of Metabolism on Epigenetics and Disease
- (2013) William G. Kaelin et al. CELL
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
- (2013) Ivan Babic et al. Cell Metabolism
- mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
- (2013) Kenta Masui et al. Cell Metabolism
- What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
- (2013) J.-A. Losman et al. GENES & DEVELOPMENT
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
- (2012) Weiwei Yang et al. CELL
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Metabolic Regulation of Epigenetics
- (2012) Chao Lu et al. Cell Metabolism
- Amino acid sensing mechanisms: an Achilles heel in cancer?
- (2012) Richard F. Lamb FEBS Journal
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
- (2012) Changho Choi et al. NATURE MEDICINE
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Reductive carboxylation supports growth in tumour cells with defective mitochondria
- (2011) Andrew R. Mullen et al. NATURE
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
- (2011) K. Masui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability
- (2011) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance
- (2011) K. Tanaka et al. Cancer Discovery
- An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway
- (2011) D. Guo et al. Cancer Discovery
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
- (2009) D. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
- (2009) D. Guo et al. Science Signaling
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started